Inovio falls after suspending stock sale program

Inovio Pharmaceuticals

02/04/2026 11:34

** Inovio Pharmaceuticals INO.O shares down 17% to around $1.45 premarket

** The biotech firm says it has suspended its at-the-market stock offering program with Oppenheimer

** Adds that the program allowed it to sell newly issued shares directly into the market

** Not to sell additional shares until filing a new prospectus - INO

** The sales agreement with Oppenheimer remains in place, but no new issuance is planned, company adds

** Inovio says sold about 1.3 mln shares under the program, raising roughly $3.2 mln before fees

** Says filing was signed by CFO Peter Kies

** As of last close, shares flat YTD

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))